Special Committee On Drug Prices – Industry Refutes Long-Term Product And Generic Drug Prices
This article was originally published in PharmAsia News
Executive Summary
The Central Social Insurance Medical Council (Chuikyo) and Special Committee on Drug Prices, who are holding discussions regarding the next prescription drug pricing system reforms, heard expert opinions July 18 regarding drug price cuts and the promotion of the use of generic drugs.